Long-Term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights From VALOR-HCM Trial.
Document Type
Article
Publication Date
3-31-2025
Publication Title
Circulation. Genomic and precision medicine
First Page
e005100
Recommended Citation
Desai MY, Owens A, Saberi S, Wang A, Wolski K, Cremer PC, et al [ Fermin D] Long-term effects of mavacamten on patients based on hypertrophic cardiomyopathy pathogenic genetic variant status: insights from VALOR-HCM trial. Circ Genom Precis Med. 2025 Mar 31:e005100. doi: 10.1161/CIRCGEN.125.005100. Epub ahead of print. PMID: 40163785.
DOI
10.1161/CIRCGEN.125.005100
ISSN
2574-8300
PubMed ID
40163785
COinS